Coya Therapeutics, Inc.
COYAAs of the close on Sep 25, 2026
Price
$5.08
Market cap
$119M
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Coya Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 5 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Apr 9, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| JANE STREET GROUP, LLC | 2026-03-31 | 13,340 | Not shown | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 3 | Not shown | SEC filing |
| Jump Financial, LLC | 2026-03-31 | 21,000 | Not shown | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 8,563 | Not shown | SEC filing |
| HRT FINANCIAL LP | 2026-03-31 | 13,517 | Not shown | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 85,700 | Not shown | SEC filing |
| BFSG, LLC | 2026-03-31 | 3,455 | Not shown | SEC filing |
| 683 Capital Management, LLC | 2026-03-31 | 70,000 | Not shown | SEC filing |
| Cetera Investment Advisers | 2026-03-31 | 30,000 | Not shown | SEC filing |
| Allworth Financial LP | 2026-03-31 | 1,000 | Not shown | SEC filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2026-03-31 | 10,000 | Not shown | SEC filing |
| JONES FINANCIAL COMPANIES LLLP | 2026-03-31 | 44,960 | Not shown | SEC filing |
| PRELUDE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 101,330 | Not shown | SEC filing |
| CITADEL ADVISORS LLC | 2026-03-31 | 16,859 | Not shown | SEC filing |
| HighTower Advisors, LLC | 2026-03-31 | 10,029 | Not shown | SEC filing |
| JPMORGAN CHASE & CO | 2026-03-31 | 5,000 | Not shown | SEC filing |
| RAYMOND JAMES FINANCIAL INC | 2026-03-31 | 11,673 | Not shown | SEC filing |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 2026-03-31 | 20,626 | Not shown | SEC filing |
| Squarepoint Ops LLC | 2026-03-31 | 40,465 | Not shown | SEC filing |
| OCCUDO QUANTITATIVE STRATEGIES LP | 2026-03-31 | 23,642 | Not shown | SEC filing |
- Each value is checked against Coya Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- ROYAL BANK OF CANADA: 27,436 shares reported 2025-12-31; 13,392 shares reported 2026-03-31.
- Triumph Capital Management: 50 shares reported 2025-12-31; 50 shares reported 2026-03-31.
- AIGH Capital Management LLC: 975,404 shares reported 2025-12-31; 975,404 shares reported 2026-03-31.
- Long Corridor Asset Management Ltd: 38,766 shares reported 2025-12-31; 38,766 shares reported 2026-03-31.
- MARSHALL WACE, LLP: 225,358 shares reported 2025-12-31; 225,792 shares reported 2026-03-31.
- SUSQUEHANNA INTERNATIONAL GROUP, LLP: 124,831 shares reported 2025-12-31; 39,316 shares reported 2026-03-31.
- WESTWOOD HOLDINGS GROUP INC: 36,660 shares reported 2025-12-31; 36,003 shares reported 2026-03-31.
- State of Wyoming: 4,184 shares reported 2025-12-31; 4,156 shares reported 2026-03-31.
- UBS Group AG: 35,035 shares reported 2025-12-31; 38,564 shares reported 2026-03-31.
- XTX Topco Ltd: 33,070 shares reported 2025-12-31; 47,338 shares reported 2026-03-31.
- OPPENHEIMER & CO INC: 14,000 shares reported 2025-12-31; 18,000 shares reported 2026-03-31.
- GHP Investment Advisors, Inc.: 26,171 shares reported 2025-12-31; 26,171 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
25 filers have only one report here.
Independent insiders buying near the same time
- 2024-11-11–2024-11-14: 4 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2023-01-03–2023-01-03: 7 event(s) across 7 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing )
- 2023-01-03–2023-01-03: 7 event(s) across 7 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2024-11-14 | SNYDER DAVID S · Chief Financial Officer | Common Stock, par value $0.0001 per share | P — Open market or private purchase | +1,800 | 7.19 | SEC filing |
| 2024-11-13 | Swaminathan Arun · Chief Executive Officer | Common Stock, par value $0.0001 per share | P — Open market or private purchase | +5,000 | 7.36 | SEC filing |
| 2024-11-11 | Grossman Fred · Chief Medical Officer | Common Stock, par value $0.0001 per share | P — Open market or private purchase | +2,710 | 7.37 | SEC filing |
| 2024-11-11 | Swaminathan Arun · Chief Executive Officer | Common Stock, par value $0.0001 per share | P — Open market or private purchase | +5,000 | 7.34 | SEC filing |
| 2023-08-22 | Lee Ann · Director | Common Stock, par value $0.0001 per share | P — Open market or private purchase | +1,000 | 3.62 | SEC filing |
| 2023-01-03 | Villalobos Anabella · Director | Common Stock, par value $0.0001 per share | P — Open market or private purchase | +10,000 | unknown | SEC filing |
| 2023-01-03 | Villalobos Anabella · Director | Warrant to Purchase Common Stock | P — Open market or private purchase | +5,000 | unknown | SEC filing |
| 2023-01-03 | Hepner Adrian · Chief Medical Officer | Common Stock, par value $0.0001 per share | P — Open market or private purchase | +10,000 | unknown | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-04-09 | Pavao Mark H · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-01-22 | Grossman Fred · Chief Medical Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +140,041 | SEC filing |
| 2026-01-22 | SNYDER DAVID S · Chief Financial Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +140,041 | SEC filing |
| 2026-01-22 | Berman Howard · Executive Chairman | Stock Option (right to buy) | A — Grant, award, or other acquisition | +15,257 | SEC filing |
| 2026-01-22 | Swaminathan Arun · Chief Executive Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +293,983 | SEC filing |
| 2026-01-02 | Weinand Dieter · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-01-02 | GOLDSTEIN DOV A MD · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-01-02 | ROSS WILBUR L JR · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
Showing 8 of 14 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.